The effect of catechol-O-methyltransferase polymorphism on the levodopa pharmacokinetics after co-administration of single dose of levodopa and entacapone in Parkinsonian patients

被引：0
|
作者：
Wu, RM
Yu, IW
Ho, YF
Kuo, JW
Chern, H
机构：
来源：
MOVEMENT DISORDERS | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P119
引用
下载
收藏
页码：S50 / S51
页数：2
相关论文
共 50 条
  • [21] Genotypes of catechol-O-methyltransferase and response to levodopa treatment in patients with Parkinson's disease
    Lee, MS
    Lyoo, CH
    Ulmanen, I
    Syvänen, AC
    Rinne, JO
    NEUROSCIENCE LETTERS, 2001, 298 (02) : 131 - 134
  • [22] Effect of the catechol-O-methyltransferase inhibitor entacapone on the steady-state pharmacokinetics and pharmacodynamics of warfarin
    Dingemanse, J
    Meyerhoff, C
    Schadrack, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (05) : 485 - 491
  • [23] CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITOR RO 40-7592 PROLONGS DURATION OF ACTION OF LEVODOPA CARBIDOPA IN PARKINSONIAN-PATIENTS
    ROBERTS, JW
    CORALOCATELLI, G
    BRAVI, D
    METMAN, LV
    MOURADIAN, MM
    CHASE, TN
    NEUROLOGY, 1993, 43 (04) : A332 - A332
  • [24] EFFECT OF ENTACAPONE, A COMT INHIBITOR, ON THE PHARMACOKINETICS AND METABOLISM OF LEVODOPA AFTER ADMINISTRATION OF CONTROLLED-RELEASE LEVODOPA-CARBIDOPA IN VOLUNTEERS
    AHTILA, S
    KAAKKOLA, S
    GORDIN, A
    KORPELA, K
    HEINAVAARA, S
    KARLSSON, M
    WIKBERG, T
    TUOMAINEN, P
    MANNISTO, PT
    CLINICAL NEUROPHARMACOLOGY, 1995, 18 (01) : 46 - 57
  • [25] Catechol-O-methyltransferase inhibition improves levodopa-associated strength increase in patients with Parkinson disease
    Mueller, Thomas
    Kolf, Kira
    Ander, Lema
    Woitalla, Dirk
    Muhlack, Siegfried
    CLINICAL NEUROPHARMACOLOGY, 2008, 31 (03) : 134 - 140
  • [26] THE EFFECT OF CATECHOL-O-METHYL TRANSFERASE INHIBITION BY ENTACAPONE ON THE PHARMACOKINETICS AND METABOLISM OF LEVODOPA IN HEALTHY-VOLUNTEERS
    KERANEN, T
    GORDIN, A
    HARJOLA, VP
    KARLSSON, M
    KORPELA, K
    PENTIKAINEN, PJ
    RITA, H
    SEPPALA, L
    WIKBERG, T
    CLINICAL NEUROPHARMACOLOGY, 1993, 16 (02) : 145 - 156
  • [27] The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson's disease: opicapone versus entacapone
    Leta, Valentina
    van Wamelen, Daniel J.
    Aureli, Federico
    Metta, Vinod
    Trivedi, Dhaval
    Cortelli, Pietro
    Rodriguez-Blazquez, Carmen
    Rizos, Alexandra
    Ray Chaudhuri, K.
    JOURNAL OF NEURAL TRANSMISSION, 2023, 130 (07) : 925 - 930
  • [28] The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson’s disease: opicapone versus entacapone
    Valentina Leta
    Daniel J. van Wamelen
    Federico Aureli
    Vinod Metta
    Dhaval Trivedi
    Pietro Cortelli
    Carmen Rodriguez-Blazquez
    Alexandra Rizos
    K. Ray Chaudhuri
    Journal of Neural Transmission, 2023, 130 : 925 - 930
  • [29] The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease
    Bialecka, M
    Drozdzik, M
    Klodowska-Duda, G
    Honczarenko, K
    Gawronska-Szklarz, B
    Opala, G
    Stankiewicz, J
    ACTA NEUROLOGICA SCANDINAVICA, 2004, 110 (04): : 260 - 266
  • [30] Genetic variations in catechol-O-methyltransferase gene are associated with levodopa response variability in Chinese patients with Parkinson's disease
    Zhao, Cuiping
    Wang, Yihua
    Zhang, Bin
    Yue, Yaoxian
    Zhang, Jianyuan
    SCIENTIFIC REPORTS, 2020, 10 (01)
12345